Seattle Genetics, Astellas Pharma Reports Initiation Of Phase 1b Trial Of Enfortumaba Vedotin In Combo With Immune Checkpoint Inhibitor Therapeies In Locally Advanced, Metastatic Urothelial Cancer: 'ADC Combination Study Focuses on First-Line Treatment'